KeyBank National Association’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$967K Sell
11,238
-2,869
-20% -$252K ﹤0.01% 666
2026
Q1
$1.28M Buy
14,107
+968
+7% +$88.8K ﹤0.01% 541
2025
Q4
$1.18M Buy
13,139
+429
+3% +$40.7K ﹤0.01% 550
2025
Q3
$1.25M Sell
12,710
-396
-3% -$39.2K ﹤0.01% 539
2025
Q2
$1.2M Sell
13,106
-1,209
-8% -$117K ﹤0.01% 538
2025
Q1
$1.62M Buy
14,315
+5,434
+61% +$581K 0.01% 458
2024
Q4
$938K Buy
8,881
+52
+0.6% +$5.58K ﹤0.01% 578
2024
Q3
$953K Sell
8,829
-266
-3% -$29K ﹤0.01% 575
2024
Q2
$987K Sell
9,095
-253
-3% -$29.8K ﹤0.01% 540
2024
Q1
$1.23M Sell
9,348
-198
-2% -$24.7K 0.01% 484
2023
Q4
$1.16M Buy
9,546
+409
+4% +$45.6K 0.01% 481
2023
Q3
$1.03M Sell
9,137
-76
-0.8% -$9.65K ﹤0.01% 463
2023
Q2
$1.34M Buy
9,213
+88
+1% +$12K 0.01% 430
2023
Q1
$1.18M Sell
9,125
-1,316
-13% -$165K 0.01% 453
2022
Q4
$1.33M Buy
10,441
+2,187
+26% +$254K 0.01% 416
2022
Q3
$863K Sell
8,254
-1,311
-14% -$144K ﹤0.01% 479
2022
Q2
$1M Buy
9,565
+75
+0.8% +$8.9K ﹤0.01% 459
2022
Q1
$1.21M Sell
9,490
-676
-7% -$81.5K 0.01% 461
2021
Q4
$1.25M Buy
10,166
+303
+3% +$39.7K 0.01% 499
2021
Q3
$1.4M Sell
9,863
-651
-6% -$95.8K 0.01% 464
2021
Q2
$1.64M Sell
10,514
-4,903
-32% -$794K 0.01% 418
2021
Q1
$2.4M Buy
15,417
+1,649
+12% +$255K 0.01% 346
2020
Q4
$2.06M Sell
13,768
-362
-3% -$51.1K 0.01% 356
2020
Q3
$1.87M Sell
14,130
-384
-3% -$50.2K 0.01% 347
2020
Q2
$1.68M Buy
14,514
+10
+0.1% +$1.15K 0.01% 354
2020
Q1
$1.42M Sell
14,504
-527
-4% -$69.1K 0.01% 352
2019
Q4
$2.18M Buy
15,031
+443
+3% +$61.1K 0.01% 345
2019
Q3
$1.94M Sell
14,588
-307
-2% -$39.7K 0.01% 354
2019
Q2
$1.7M Sell
14,895
-708
-5% -$82.9K 0.01% 395
2019
Q1
$1.94M Sell
15,603
-2,617
-14% -$297K 0.01% 362
2018
Q4
$1.83M Sell
18,220
-1,839
-9% -$207K 0.01% 354
2018
Q3
$2.56M Sell
20,059
-1,111
-5% -$132K 0.01% 315
2018
Q2
$2.29M Sell
21,170
-3,298
-13% -$359K 0.01% 330
2018
Q1
$2.59M Sell
24,468
-13,852
-36% -$1.61M 0.02% 312
2017
Q4
$4.49M Sell
38,320
-7,159
-16% -$810K 0.03% 260
2017
Q3
$5.17M Sell
45,479
-2,121
-4% -$245K 0.03% 249
2017
Q2
$5.93M Sell
47,600
-2,375
-5% -$282K 0.04% 235
2017
Q1
$5.92M Sell
49,975
-1,612
-3% -$183K 0.04% 237
2016
Q4
$5.17M Sell
51,587
-1,470
-3% -$158K 0.03% 244
2016
Q3
$6.7M Sell
53,057
-343
-0.6% -$42.4K 0.04% 220
2016
Q2
$6.24M Sell
53,400
-1,636
-3% -$185K 0.04% 219
2016
Q1
$5.7M Sell
55,036
-475
-0.9% -$46K 0.04% 227
2015
Q4
$5.53M Sell
55,511
-796
-1% -$77.9K 0.04% 235
2015
Q3
$5.13M Sell
56,307
-1,579
-3% -$158K 0.04% 250
2015
Q2
$6.14M Sell
57,886
-907
-2% -$100K 0.04% 242
2015
Q1
$6.71M Sell
58,793
-196
-0.3% -$22.4K 0.04% 237
2014
Q4
$6.5M Sell
58,989
-193
-0.3% -$20.3K 0.04% 241
2014
Q3
$5.78M Sell
59,182
-1,059
-2% -$104K 0.04% 255
2014
Q2
$6.07M Sell
60,241
-16,151
-21% -$1.58M 0.04% 245
2014
Q1
$7.01M Sell
76,392
-56,590
-43% -$5.22M 0.05% 226
2013
Q4
$12M Buy
132,982
+55,219
+71% +$4.78M 0.08% 175
2013
Q3
$6.2M Sell
77,763
-1,230
-2% -$96.8K 0.04% 241
2013
Q2
$5.75M Buy
+78,993
New +$5.91M 0.02% 480

Other funds holding ZBH

KeyBank National Association's ZBH Position: Q2 2026 in Review

KeyBank National Association reduced its Zimmer Biomet (ZBH) stake by 20% in Q2 2026, selling an estimated $252K and leaving 11,238 shares worth $967K. The position accounts for ﹤0.01% of the portfolio, ranked #666.

KeyBank National Association first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $12M in Q4 2013. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • KeyBank National Association held 11,238 shares of Zimmer Biomet worth $967K as of Q2 2026.
  • KeyBank National Association sold 2,869 Zimmer Biomet shares in Q2 2026, an estimated $252K.
  • Zimmer Biomet made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #666 holding.
  • KeyBank National Association first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • KeyBank National Association's Zimmer Biomet position peaked at $12M in Q4 2013.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.